4 Midcap Promoter Backed Fast Revenue Growth and High ROE Stocks to Watch for Future Multibagger Potential: Waaree, Kalyan, NMDC and Ajanta

Promoter backed fast revenue growth and high ROE stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Waaree, Kalyan, NMDC and Ajanta meet that test, with market caps from Rs 41,786 crore to Rs 75,570 crore and Waaree offering the highest return on equity at 25.71%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a promoter holding of at least 50 per cent, FY26 revenue growth of at least 15 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a promoter holding of at least 50 per cent, FY26 revenue growth of at least 15 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening promoter backed fast revenue growth and high ROE stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 11 November 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Promoter Backed Fast Revenue Growth and High ROE Stocks and Why Do They Attract Multibagger Interest?

Promoter backed fast revenue growth and high ROE stocks are shares of mid sized companies in which the promoters own at least half of the business, whose sales grew by fifteen per cent or more in FY26 and whose return on equity is twenty per cent or more. The four here cover solar modules, iron ore mining, jewellery retail and pharmaceuticals.

Owners with a large stake have their own wealth tied to the company, fast sales growth shows demand, and a high return on equity shows that shareholder money is used well while the business expands. Within promoter backed fast revenue growth and high ROE stocks, the four companies show rising profit. In promoter backed fast revenue growth and high ROE stocks, each of the four also posted growth in the latest quarter. For promoter backed fast revenue growth and high ROE stocks, both FY26 and the latest quarter showed growth. Whichever way you read promoter backed fast revenue growth and high ROE stocks, the common thread is rising profit backed by complete financial data. With promoter backed fast revenue growth and high ROE stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for promoter backed fast revenue growth and high ROE stocks are complete. Read each company's latest results and exchange filings before acting on promoter backed fast revenue growth and high ROE stocks.

Promoter Backed Fast Revenue Growth and High ROE Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 11 November 2026. NMDC has the lowest PE of the group at 8.70, while Waaree posts the highest return on equity at 25.71%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Waaree Energies	2,500	75,570	18.88	45.89	25.71%	0.22	2,238.00 to 3,718.80
Kalyan Jewellers India	663.75	69,367	48.36	46.75	21.41%	0.97	327.05 to 663.75
NMDC	71.70	64,905	8.70	10.06	21.87%	0.19	66.35 to 97.49
Ajanta Pharma	3,319.60	41,786	36.82	36.35	23.33%	0.06	2,380.20 to 3,796.00

Waaree: Revenue Up 83.52% in FY26

Waaree Energies is one of India's largest solar module makers by capacity and manufactures solar cells and modules. It reported FY26 revenue of Rs 27,244.92 crore, up 83.52% year on year, and net profit of Rs 3,884.15 crore, up 101.45%. Revenue has compounded at 74.31% a year since FY22. Operating margin was 23.82% in FY26. The debt-to-equity ratio is 0.22.

In the June 2026 quarter, revenue rose 76.25% to Rs 8,102.60 crore and net profit grew 15.39% to Rs 891.87 crore. Domestic institutions raised their holding from 2.82% in September 2025 to 4.09% in September 2026. The stock trades at a PE of 18.88 against an industry PE of 45.89, below the sector average, with a return on equity of 25.71%.

Kalyan: 56.69% Profit CAGR Since FY22

Kalyan Jewellers is one of the largest jewellery retailers in India, with showrooms across India and the Middle East. It reported FY26 revenue of Rs 35,950.88 crore, up 42.72% year on year, and net profit of Rs 1,350.39 crore, up 89.09%. Net profit has compounded at 56.69% a year since FY22, while revenue has grown 34.90% a year. Operating margin was 7.62% in FY26.

The stock trades at a PE of 48.36 against an industry PE of 46.75, with a return on equity of 21.41%. In the June 2026 quarter, revenue rose 45.52% to Rs 10,644.67 crore and net profit grew 32.03% to Rs 348.67 crore. The share price has gained 647.75% over five years and 19.61% over the past year. Promoters hold 62.85%, which keeps ownership stable.

NMDC: Revenue Up 31.61% in FY26

NMDC is a government-owned miner and India's largest iron ore producer. It reported FY26 revenue of Rs 33,559.27 crore, up 31.61% year on year, and net profit of Rs 7,415.37 crore, up 13.39%. Revenue has compounded at 5.90% a year since FY22. Operating margin was 33.51% in FY26. The debt-to-equity ratio is 0.19.

In the June 2026 quarter, revenue rose 1.47% to Rs 7,142.54 crore and net profit grew 1.94% to Rs 2,005.71 crore. Foreign investors raised their holding from 12.21% in June 2025 to 13.59% in June 2026. The stock trades at a PE of 8.70 against an industry PE of 10.06, below the sector average, with a return on equity of 21.87%. The dividend yield is 4.75%.

Ajanta: Return on Equity of 23.33%

Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

The stock trades at a PE of 36.82 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.11% over five years and 35.30% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.

Promoter Backed Fast Revenue Growth and High ROE Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these promoter backed fast revenue growth and high ROE stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Waaree	27,244.92	3,884.15	83.52%	74.31%	76.25%	20.31%
Kalyan	35,950.88	1,350.39	42.72%	34.90%	45.52%	6.50%
NMDC	33,559.27	7,415.37	31.61%	5.90%	1.47%	41.43%
Ajanta	5,624.93	1,056	18.60%	12.94%	27.68%	30.41%

Check the Univest Screener for live data on these promoter backed fast revenue growth and high ROE stocks

Institutional Holding in Waaree, Kalyan, NMDC and Ajanta

Institutional holding shows who is backing these promoter backed fast revenue growth and high ROE stocks alongside the promoter. The table uses the latest reported quarter for each. Ajanta has the deepest institutional backing, with FII and DII together holding 29.57% as of September 2026. Domestic institutions increased their holding over the past year in Waaree (from 2.82% to 4.09%) and Ajanta (from 17.90% to 21.94%). To see how this group fits the wider market, many investors compare it with the Nifty Midcap 100.

Stock	Promoter	FII	DII	Public	Quarter
Waaree	64.12%	8.57%	4.09%	23.22%	September 2026
Kalyan	62.85%	13.83%	14.41%	8.91%	September 2026
NMDC	60.79%	13.59%	13.81%	11.80%	June 2026
Ajanta	63.47%	7.63%	21.94%	6.96%	September 2026

Risks to Weigh in Promoter Backed Fast Revenue Growth and High ROE Stocks

Being careful with promoter backed fast revenue growth and high ROE stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Kalyan trades at a PE of 48.36 against an industry PE of 46.75, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Promoter Backed Fast Revenue Growth and High ROE Stocks

Picking from promoter backed fast revenue growth and high ROE stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (10.06 to 46.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Waaree, Kalyan, NMDC and Ajanta live prices.

Conclusion

Among promoter backed fast revenue growth and high ROE stocks, Waaree stands out for the highest return on equity at 25.71%, Kalyan for the fastest profit growth, 56.69% a year since FY22, NMDC for the lowest PE of the group at 8.70 and Ajanta for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing promoter backed fast revenue growth and high ROE stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Promoter Backed Fast Revenue Growth and High ROE Stocks to Watch

Which are the best promoter backed fast revenue growth and high ROE stocks to watch for multibagger potential?

Ans. Waaree, Kalyan, NMDC and Ajanta are the 4 names this list highlights, with market caps of Rs 75,570 crore, Rs 69,367 crore, Rs 64,905 crore and Rs 41,786 crore respectively. Waaree is notable for the highest return on equity at 25.71%. Kalyan stands out for the fastest profit growth, 56.69% a year since FY22. NMDC offers the lowest PE of the group at 8.70. Ajanta brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. These are watchlist names for promoter backed fast revenue growth and high ROE stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Waaree a good stock for long-term investors?

Ans. Waaree has a return on equity of 25.71%, a PE of 18.88 against an industry PE of 45.89 and a market cap of Rs 75,570 crore. FY26 revenue rose 83.52%, and June 2026 quarter net profit grew 15.39%. Long-term returns in promoter backed fast revenue growth and high ROE stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Kalyan become a multibagger from here?

Ans. Kalyan has already gained 647.75% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in promoter backed fast revenue growth and high ROE stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 56.69% a year since FY22, and FY26 revenue rose 42.72%. At a PE of 48.36 against an industry PE of 46.75, valuation should be checked against that growth before investing.

What is the market cap of Waaree, Kalyan, NMDC and Ajanta?

Ans. As of 11 November 2026, Waaree has a market cap of Rs 75,570 crore, Kalyan has a market cap of Rs 69,367 crore, NMDC has a market cap of Rs 64,905 crore and Ajanta has a market cap of Rs 41,786 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on promoter backed fast revenue growth and high ROE stocks.

What are the risks of investing in promoter backed fast revenue growth and high ROE stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Kalyan trades at a PE of 48.36 against an industry PE of 46.75, so earnings growth needs to hold up.

Is NMDC trading below its industry PE?

Ans. NMDC trades at a PE of 8.70 against an industry PE of 10.06. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (FY26 revenue rose 31.61% and June 2026 quarter net profit grew 1.94%) and balance sheet strength before drawing a conclusion.

How much do institutions hold in Waaree, Kalyan, NMDC and Ajanta?

Ans. As of the latest reported quarter, FII and DII together hold 12.66% of Waaree (8.57% and 4.09%), 28.24% of Kalyan (13.83% and 14.41%), 27.40% of NMDC (13.59% and 13.81%) and 29.57% of Ajanta (7.63% and 21.94%). Rising institutional holding is a useful signal in promoter backed fast revenue growth and high ROE stocks, though it should be read with earnings trends rather than on its own.